Nasometin (Mometasone Furoate)

Mometasone Furoate, the active ingredient in Nasometin, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis, seasonal allergic rhinitis and nasal polyps in both adults and children by reducing inflammation of the nasal mucosa and relieving congestion, sneezing and nasal discharge.

GNH USA supplies Nasometin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone Furoate nasal spray acts on inflammatory pathways of the nasal mucosa to control allergic and polyp‑related conditions. - Allergic rhinitis: reduces nasal inflammation and alleviates congestion, sneezing and itching. - Seasonal allergic rhinitis: provides symptom relief during pollen seasons by decreasing mucosal swelling. - Nasal polyps: helps shrink polyps and improves nasal airflow, reducing obstruction and associated symptoms.

Adverse reactions may occur with nasal administration of mometasone furoate.

Common Side Effects: - Nasal irritation or burning sensation - Headache - Epistaxis (nosebleeds) - Throat irritation or dryness - Cough - Altered taste or smell

Serious or Rare Side Effects: - Adrenal suppression - Glaucoma or increased intra‑ocular pressure - Cataract formation - Severe or persistent nosebleeds - Nasal fungal infection - Systemic immunosuppression leading to opportunistic infections

Before using Nasometin, consider the following safety measures. - Assess for active nasal infection: avoid use if bacterial or fungal infection is present. - Use the lowest effective dose: limit exposure to reduce systemic absorption. - Avoid prolonged use without medical supervision: regular review is recommended. - Monitor for signs of adrenal insufficiency: fatigue, weakness, hypotension. - Caution in patients with glaucoma or cataracts: monitor intra‑ocular pressure. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasone Furoate nasal spray may interact with other medicines.

Major Interactions (Avoid): - Systemic corticosteroids: additive glucocorticoid effects may increase risk of adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise local exposure and systemic absorption. - Live vaccines: immunosuppressive action could reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamines: possible additive sedation or anticholinergic effects. - Nasal decongestants (e.g., oxymetazoline): may increase local irritation or rebound congestion.